Novel combination therapy may help overcome mTOR drug resistance in AML
Soon after rapamycin, the first mTOR inhibitor, emerged in 1990s as a potential treatment against unwanted cell proliferation, many cancer experts had hoped emerging drugs targeting mTOR would become a breakthrough targeted ...
Dec 21, 2020
0
29